The global fold of human cannabinoid type 2 (CB 2 ) receptor in the agonist-bound active state in lipid bilayers was investigated by solid-state 13 C-and 15 N magic-angle spinning (MAS) NMR, in combination with chemical-shift prediction from a structural model of the receptor obtained by microsecond-long molecular dynamics (MD) simulations. Uniformly 13 C-and 15 N-labeled CB 2 receptor was expressed in milligram quantities by bacterial fermentation, purified, and functionally reconstituted into liposomes.
INTRODUCTION
The cannabinoid CB 2 receptor is a member of the class A (rhodopsin family) of G protein-coupled receptors (GPCR). It is found primarily in tissues of immune and hematopoietic systems like spleen, tonsil, and thymus, where it controls function of immune cells. 1 Evidence has been presented that the CB 2 receptor is also present in brain, which makes the previous classification of CB 2 as peripheral cannabinoid receptor obsolete. 2 Experimental determination of the receptor structure is critical for elucidating molecular mechanisms of receptor function.
GPCR have a common structural motif of seven transmembrane a-helices which are alternately connected via intra-and extracellular loops. For several GPCR, the structure at atomic resolution was recently unveiled by xray crystallography including bovine rhodopsin, 3-5 adenosine A 2A receptor, 6 b-adrenergic receptors, 7,8 CXCR4 chemokine receptor, 9 dopamine D3 receptor, 10 muscarinic acetylcholine receptors, 11,12 S1P 1 receptor, 13 histamine H 1 receptor, 14 nociceptin/orphanin FQ receptor, 15 opioid receptors, 16-18 protease activated receptor, 19 neurotensin receptor, 20 serotonin receptors, 21,22 smoothened receptor, 23 and glucagon receptor. 24 Crystallographic results provided valuable information, such as the configuration of amino acid residues composing the ligand binding pocket, the arrangement of transmembrane helices, as well as the existence of amphipathic helix VIII near the intracellular end of helix VII. The recently published structure of a cocrystallized GPCR-G protein complex revealed the sites of interactions with G protein as well as the structural changes in GPCR upon activation. 25, 26 The availability of crystallographic data has stimulated interest and highlighted the necessity of studying structure and function of GPCR in their natural environment, the lipid bilayer, without conformational constraints from crystal packing. 27 Such experimental conditions are accessible by solid-state NMR spectroscopy. Recently, the chemokine receptor CXCR1 in DMPC bilayers was studied by solid-state NMR. 28 The secondary structure was obtained from measured and assigned chemical shifts of the backbone 13 C-and 15 N resonances of the protein. The global fold of the receptor was obtained by energy minimization using a homology model to rhodopsin with extensive experimental restraints from orientationdependent 1 H- 13 C a and 1 H-15 N dipolar couplings. 28 A prerequisite for structural studies by NMR is availability of purified, functional protein in the low milligram range. The expression levels of CB 2 receptor as well as of other GPCR in their natural host cells are quite low, except for visual rhodopsin that is highly concentrated in the disc membranes of retinal rod outer segment. Therefore, heterologous expression using mammalian-, insect-, yeast-, or bacterial cells as well as cell-free expression are used to produce the quantities of GPCR required for structural investigations. 29-31 Furthermore, for NMR studies the expression system must be adapted to efficiently incorporate stable 13 C, 15 N, isotopes into the target protein which requires modification of expression protocols. Isotope labeling of ligands, on the other hand, requires modified schemes of chemical synthesis. 27,32 Although a variety of expression hosts have been adapted to isotopic labeling, the use of a robust and efficient bacterial expression system is still the first choice for flexibility in planning of labeling schemes. E. coli cells grow well in minimal media of a defined composition which simplifies procedures for the incorporation of isotope-labeled precursors into the recombinant receptor.
Previously, we reported results on (i) E. coli expression of CB 2 receptor as a fusion with maltose binding protein (MBP) and removal of expression partners, (ii) chromatographic purification of the receptor at the level of milligrams, 33-35 (iii) stabilization of the receptor in micelles, 36 and (iv) detergent-free, homogeneous reconstitution into liposomes while maintaining function. 27 Large scale production of functional CB 2 receptor by fermentation of E. coli cells in a mineral salt medium (MSM) was also demonstrated. 37 Here we report on expression, purification, and functional reconstitution of agonist CP-55,940-activated, uniformly 13 C-, 15 N-labeled cannabinoid receptor CB 2 and first structural studies by solid-state NMR. We optimized expression conditions to produce uniformly 13 C-, 15 Nlabeled CB 2 receptor while minimizing the use of 13 Clabeled glucose. The latter is essential since yields of recombinant CB 2 per unit of biomass 37 are much lower than for soluble proteins or membrane proteins expressed as inclusion bodies. Typical expression protocols would have required quantities of 13 C-labeled glucose that are cost prohibitive. Uniform labeling of the receptor with 15 N is easily achieved by supplementation of the MSM with the relatively inexpensive 15 N-ammonium salts.
One-dimensional 13 C-and 15 N-MAS NMR spectra of the labeled CB 2 receptor were acquired for a quantitative comparison with simulated spectra derived from the atomic coordinates of MD simulations of the receptor. 38 The isotropic chemical shifts of proteins for the backbone 13 C a -, 13 C@O-, 15 NH-, and the side-chain 13 C aresonances reflect sensitively the amino acid sequence, secondary structure, side-chain conformations, and through-space interactions between amino acid residues. 39-45 Therefore, the chemical shift distribution of the recombinant CB 2 receptor measured by MAS NMR, containing contributions from resonances of all the 400 amino acid residues, is tightly linked to the global fold of the protein. Spin-spin (T 2 ) relaxation times were measured as well to calculate the relaxation linewidth of resonances. We also acquired two-dimensional 13 
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13 C and 13 CA 15 N correlation spectra with the intention to resolve and assign resonances. However, for reasons discussed later, we did not achieve the required sensitivity and resolution that would have enabled assignment. Nevertheless, the measured distribution of chemical shifts, in particular the distribution of the C a resonances reveals valuable information on the global fold of the recombinant CB 2 .
The model of the CB 2 receptor employed here is based on the crystal structure of the Class A GPCR, rhodopsin in the dark-adapted state. 4 The rhodopsin structure was chosen as the template because no modifications were made to its structure in order to crystallize it. In addition, rhodopsin shares some unusual sequence motifs with the cannabinoid receptors, including the GWXC motif at the extracellular end of transmembrane helix IV that forms an aromatic stacking interaction with Y5.39.
This interaction affects the extracellular positions of transmembrane helices III-V and is therefore important for CB 2 . We calculated low free energy conformations for any transmembrane helices with an important sequence divergence from rhodopsin. Specifically, in transmembrane helix II there is a pair of glycines that distort the helix while CB 2 has no equivalent distortion; similarly, residue 5.50 is a proline in rhodopsin but not in CB 2 .
The resultant model has been tested by substituted cysteine accessibility studies to identify residues that face into the CB 2 binding pocket, 46,47 by mutation to identify key ligand interactions sites, 46-49 and by covalent labeling of CB 2 50 to identify the method of ligand entry into the CB 2 binding pocket.
The CB 2 receptor model was then inserted into a lipid bilayer composed of 123 molecules of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 38 molecules of the endogenous ligand 2-arachidonyl-glycerol (2-AG). 38 A spontaneous binding of a 2-AG molecule from the lipid matrix to the ligand binding site observed in the simulations yielded the structure of agonistactivated CB 2 receptor that was compared with experimental results for agonist CP-55,940-bound receptor. The structure of CB 2 before 2-AG binding was defined as the inactive state of the receptor. Spectral prediction was performed using the programs SHIFTX 51 and SPARTA, 52 which calculate the chemical shift values semiempirically based on databases of previously reported protein structures with resonance assignments. The sensitivity of spectra to changes in the primary amino acid sequence and to secondary structure is demonstrated.
The experiments and spectral predictions are useful for developing strategies for specific labeling of amino acids that are likely to yield well resolved and assigned resonances in multidimensional NMR experiments. The CB 2 model was also used to show that selective amino acid labeling schemes can be used for elucidation of mechanisms of receptor activation.
MATERIALS AND METHODS
Information on chemicals, the protein expression protocol including composition of media, protein purification and reconstitution, and molecular dynamics calculations are provided in the Supporting Information.
C MAS NMR
The proteoliposomes containing uniformly 13 C-, 15 Nlabeled CB 2 receptor were pelleted by ultracentrifugation at 417,200g for 12 h at 4 C. The pellet was transferred to a 4-mm MAS rotor with a 50-lL sample volume sealed by a Kel-F insert (Bruker BioSpin, Billerica, MA). The 13 C MAS NMR spectra of proteoliposomes were recorded at a 13 C resonance frequency of 201.21 MHz on an AV800 spectrometer equipped with a 4-mm 1 H/ 13 C/ 15 N MAS variable-temperature probehead (Bruker BioSpin). Measurements were carried out at MAS frequencies of 10 and 15 kHz. The sample temperature was varied from 9 to 26 C. Spectra were acquired without sensitivity enhancement by crosspolarization or the nuclear Overhauser effect using a 5.0-ls 90 pulse on 13 The atomic coordinates of the CB 2 receptor were obtained from microsecond-long molecular dynamics simulations of CB 2 receptor in a lipid matrix as explained in the Introduction section. 38 An abbreviated description of simulation procedures is provided in Supporting Information. The 13 C-, and 15 N-chemical shifts of C a -, C b -, C@O-, and NH-resonances of the CB 2 receptor were predicted based on the atomic coordinates of the receptor obtained in MD simulations using the shift-prediction programs SHIFTX 51 and SPARTA. 52 The programs yield the shift values referenced to 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS). The prediction was performed on the ligand-free inactive and agonist-bound activated states of CB 2 receptor from the simulations. 38 The chemical-shift value at each atomic site was calculated as the average from five or six time points taken at intervals of 0.9 or 1 ns of the simulations. The predicted chemical shift values are expected to be accurate within standard deviations of 1.4 ppm for 13 C-and 3 ppm for 15 N-resonances when applied to membrane proteins. 55 The 13 C spectra were simulated using the predicted C a , C b , and C@O chemical shifts and assuming a linewidth of resonances of 100 Hz. In the chemical-shift prediction, the eleven histidines in wild-type CB 2 receptor were treated as deprotonated as required by programs for chemical shift prediction. For recombinant CB 2 receptor 35 (see Supporting Information Fig. S4 for amino acid sequence), the 12 histidines in the N-and C termini were also treated as deprotonated, and all amino acids in the termini were assumed to be in random coil conformation. The number of histidines is modest compared to the total number of residues (11 of 360 total in the wild type sequence, and 23 of 400 in recombinant CB 2 -130). A comparison of simulated spectra for wild-type CB 2 and recombinant CB 2 -130 suggested that the influence of histidines and their state of protonation on the shape of 13 C resonance bands is insignificant (see Supporting Information Fig. S3 ).
RESULTS AND DISCUSSION
Expression, purification, and reconstitution of 13 C-, 15 N-CB 2 receptor
Fermentation of E. coli BL21-21(DE3) harboring plasmid pAY130 for expression of 13 C-and 15 N-labeled recombinant CB 2 receptor 35 was performed in MSM containing 13 C-labeled glucose as the sole carbon source and 15 NH 4 Cl as the sole nitrogen source, and produced high density biomass that yielded 6 mg of uniformly 13 C-, 15 N-labeled, MBP-CB 2 fusion protein in the functional state. The fusion protein was solubilized from bacterial plasma membranes in a mixture of detergents CHAPS, n-dodecyl-b-D-maltopyranoside (DDM), and cholesteryl hemisuccinate (CHS) with addition of cannabinoid agonist CP-55,940. 36 Upon purification of the fusion protein on a Ni-NTA column, the MBP expression partner was removed by treatment with TEV protease. CB 2 was further purified by affinity chromatography on a StrepTactin resin as described previously. 35 Reconstitution of the purified, uniformly 13 C-, 15 Nlabeled CB 2 receptor (2.8 mg) with phospholipids (28 mg; POPC/POPS 5 4/1, mol/mol) by the rapid-dilution method yields detergent free, homogeneous proteoliposomes. 27 The recovery of protein and lipids in the proteoliposome preparation was high: 2.6 mg (92% yield) of the 13 
C MAS NMR
The NMR experiments were conducted on proteoliposomes in PBS buffer containing 2.6 mg of uniformly 13 C-, 15 N-labeled CB 2 receptor as described above, activated with agonist CP-55,940. Detection of 13 C-resonances was performed without sensitivity enhancement such as crosspolarization, INEPT, or the nuclear Overhauser effect to ensure that intensities of all 13 C-resonances of the protein are identical to enable a quantitative comparison of predicted spectra from molecular simulations and experimental results. The relaxation delay between acquisitions was sufficiently long to avoid intensity losses due to saturation.
The measured 13 C-spectrum is presented in Figure  1 Fig. 1(b) ]. The experiments also yielded the T 2 relaxation times of lipids which permitted correction of their intensities for relaxation decay. The corrected lipid spectrum was then subtracted from the combined spectrum of protein and lipids [ Fig. 1(a) ] to yield the 13 C spectrum of pure CB 2 receptor [ Fig.  1(c) ]. Experiments were conducted in the temperature range of 9-26 C, above the gel-fluid phase transition of the lipid matrix. No changes in spectral appearance as a function of temperature were observed (Supporting Information Fig. S2 ).
The T 2 relaxation experiments indicated that the C a and C@O bands have relaxation times of 2.8 and 4.2 ms, respectively (Fig. 2) , equivalent to a resonance linewidth at half height of 0.55 and 0.40 ppm. The actual linewidth could be somewhat larger due to inhomogeneous line broadening. The intrinsic resolution on the order of 0.5 ppm is encouraging for designing schemes of selectiveisotope labeling of CB 2 receptor that may yield resolved resonances with their assignments; see discussion below. The large number of resonances of the 44-kDa recombinant, uniformly 13 C-, 15 N-labeled protein in combination with the limited resolution resulted in heavy signal superposition. Nevertheless, the shape of the band of superimposed resonances reports important information on receptor fold as will be presented below. This applies in particular to the band of C a resonances which has a rather wide distribution of chemical shifts. 15 N resonances of the proline ring. The side-chain resonances of arginines and lysines upfield from the amide band were well resolved, and the side-chain resonances of histidines appear downfield. The backbone amide band plays a key role for 13 C resonance assignments when site-selectively isotopelabeled CB 2 receptor is investigated.
N MAS NMR

Multidimensional NMR experiments
2D CP-DARR 13 C- 13 C correlation experiments 57 were acquired with mixing times from 50 to 300 ms. Furthermore, we conducted 2D 15 N-13 C correlation experiments 58 yielding a selective transfer of the 15 N magnetization to directly bonded 13 C nuclei (results not 15 N resonances of CB 2 is lower which not only results in more signal superposition but also in lower sensitivity, and (ii) our lipid/protein molar ratio is higher by about a factor of 3 which resulted in a larger sample size for equal amounts of protein. The CB 2 /lipid molar ratio in bilayers is limited by stringent requirements for the presence of a proper concentration of CHS in the micellar phase to protect the receptor from denaturation. 36 The CHS from the micelles ends up quantitatively in the lipid matrix which requires addition of a higher amount of phospholipids not to exceed solubility limits for CHS in proteoliposomes. 27 The use of a 3.2 mm, low-E MAS probe with a sample volume of 36 lL 28 compared to a 4-mm MAS probe with twice the sample volume in our experiments has probably resulted in higher sensitivity for the CXCR1 experiment as well. Last but not least, functional studies on reconstituted CB 2 determined that the receptor at ambient temperature and higher denatures at a rate that prevents long-lasting three-dimensional NMR experiments. 36
Comparison to simulated spectra from a molecular model
The measured one-dimensional 13 C MAS NMR spectra of the agonist-bound CB 2 receptor in liposomes were compared to predicted spectra from MD simulations of CB 2 in the inactive and agonist activated states. In the course of the simulations, a spontaneous binding event of 2-AG to CB 2 was observed. The ligand entered the binding pocket located on the extracellular side of the receptor through a gap between transmembrane helices VI and VII. Ligand binding resulted in breaking of the ionic lock between arginine R3.55 and aspartic acid D6.30 located near the ends of transmembrane helices III and VI on the intracellular side of the receptor. This was followed by a side-chain flip at W6.48 that may correspond to the so-called rotamer toggle switch. Hence, the MD simulations report on atomic coordinates of the protein structure related to the critical steps of receptor activation from ligand-free inactive to agonist-bound active states. Atomic coordinates of the receptor were extracted from before 2-AG binding, after binding and breakage of the ionic lock, as well as before and after activation of the toggle switch. Each period in the evolution of the CB 2 structure was probed using five to six coordinate sets taken at 1-or 0.9-ns intervals to account for rapid structural fluctuations. This allowed us to predict NMR spectral changes related to the full activation process, but also for ligand binding and breakage of the ionic lock, and for activation of the toggle switch selectively.
Chemical shifts of the backbone 13 C a -, 13 C@O-, 15 NH-, and the side-chain 13 C b resonances were determined from the PDB files using the programs SHIFTX and SPARTA and averaged for each time period. Differences in spectral predictions between SHIFTX and SPARTA were insignificant (Supporting Information Fig.  S3 ). The comparison of measured and predicted spectra is shown in Figure 4 . The predicted distribution of 13 C resonances of the fully activated state of CB 2 (black spectrum) is to be compared with the experimentally recorded 13 C MAS NMR spectrum in blue. It was assumed that the simulated structure of CB 2 receptor activated by 2-AG is similar to the structure of CB 2 activated by CP-55,940 in the experiment. The predicted spectrum of ligand-free, inactive CB 2 is shown as well (grey spectrum). The green spectrum shows the predicted distribution of the C b resonances (SHIFTX and SPARTA predict only C a , C@O, and the side-chain C a resonances). The predicted distribution of the C a resonances from the simulation is in decent qualitative agreement with the experimental spectrum: the experimentally measured C a band has its highest intensity at 58. Comparison of the measured 13 C MAS NMR spectrum of the CB 2 receptor (blue) with a predicted spectrum from the MD simulations (black). The receptor is in the agonist-bound active state. The prediction was made for the backbone C a , C@O, and side-chain C b carbons by application of the chemical-shift prediction program SHIFTX. The predicted C b signals were shown explicitly to specify signals from Ser (63 ppm) and Thr (69 ppm) that appear in the C a region due to a directly bonded hydroxyl group (green). The predicted spectrum of the ligand-free inactive state of the receptor is also presented (grey) as well as the C b signals (light green).
to have significant contributions from those polar side chains.
The predicted chemical shift distribution indicated small but notable differences between inactive and active states of CB 2 receptor, particularly in the distribution of intensities in the band of C a resonances. The band intensity at 58.0 ppm decreases somewhat upon activation and an increase of intensity is predicted near 61 ppm. However, those differences would be difficult to detect in experiments using uniformly labeled CB 2 receptor, considering that the deviations between predicted and measured spectra are of similar magnitude. The predicted shape of the C@O band of resonances is almost identical for the inactive and active states except for some minor increase in intensity near 178 ppm upon activation.
To scrutinize how the intensity distribution of 13 C chemical shifts reflects secondary structure of the protein, we separately calculated contributions to the spectrum from (i) helices, (ii) loops, and (iii) N-and C-termini for C a chemical shifts (Fig. 5) . The helices include the transmembrane helices I-VII and the intracellular amphipathic helix VIII. The loops are rich in turns and somewhat ordered, while the N-and C-terminal domains are rich in random coil structure. It is obvious that the characteristic patterns of the experimental spectrum are determined by resonances of the helices of CB 2 that yield the characteristic maximum at 58 ppm. The upfield region of the C a band, to the right from the maximum contains significant contributions from resonances of turns and disordered segments in the loops and the N-, and C-termini. Indeed, C a resonances shift upfield upon a conformational transition from a-helix to random coil. 39, 42, 43 It is concluded that the experimentally measured distribution of the 13 C-resonance intensities in the C a region (45-70 ppm) sensitively reports the global fold of CB 2 in liposomes. The remaining deviations between the measured and predicted 13 C NMR spectra may have several causes: (i) The accuracy of prediction algorithms for chemical shifts of proteins has very much improved but is finite especially for comparison with chemical shifts measured by solid-state NMR. 55 (ii) The simulation of CB 2 receptor was performed on the timescale of microseconds which is unlikely to be adequate for exploration of the entire conformational space of a GPCR, although it appears that the simulations report on the most critical steps of the activation process. Furthermore, even the current simulations revealed significant motional degrees of freedom, in particular in the region of loops and the N-and C-termini. It may be necessary to conduct more extensive conformational averaging of chemical shifts using a representative set of conformations to achieve an even better agreement between experiment and simulations. 38 (iii) The CB 2 receptor in the experiment is activated by the full agonist CP-55,940 while activation in the simulation occurred by the endogenous partial agonist 2-AG. (iv) While the estimated purity of the receptor is 90% and the fraction of functionally reconstituted CB 2 receptor (>90%) 27 is rather high, the presence of some unwanted resonances may not be excluded. (v) The subtraction of natural-abundance 13 C-resonances of lipids from the spectra may not be perfect. With those limitations in mind, the agreement between measured and predicted 13 C NMR spectra of CB 2 receptor in a membrane is quite reasonable.
Changes in chemical shifts upon activation of CB 2 receptor
The availability of MD simulations of CB 2 receptor showing the effects of ligand binding, breakage of the Figure 5 The C a region of 13 C NMR spectra simulated for helices, N-and Ctermini, and loops of CB 2 compared to the full experimentally measured spectrum. The prediction was made by the program SHIFTX using the structure of activated CB 2 obtained in MD simulations.
ionic lock and activation of the rotamer toggle switch enabled us to predict which of the amino acid residues will experience significant changes of their 13 Fig. 7 ).
ICL3 constitutes a critical site for binding and activation of heterotrimeric G proteins. 26 In the CB 2 simulation, ligand binding was accompanied by breaking of the Figure 7 Predicted C a chemical-shift changes (Dd/ppm) of amino acid residues in the extracellular Loop 2 (ECL2) (a) upon activation of CB 2 receptor. 38 Amino acid residues with changes Dd greater than 61.5 ppm are marked in the snake plot: 2.0 ppm j Ddj 1.5 ppm, light blue; j Ddj 2.0 ppm, dark blue. The values in parentheses indicate the standard deviation of the chemical shift at each amino acid residue due to motional fluctuations during the 5-ns periods from inactive-(first value) and active (second value) states of the receptor, respectively. (b) Predicted changes (Dd/ ppm) due to 2-AG binding to the receptor pocket and the following breakage of the ionic lock between helices III and VI during the activation process. 38 (c) Predicted changes (Dd/ppm) due to activation of the rotamer toggle switch at W6.48 that occurred after the breakage of the ionic lock. 38 Compared to Dd from breakage of the ionic lock, Dd from activation of the toggle switch are minor despite the relatively long time monitored (600 ns). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary. com.] ionic lock between transmembrane helices III and VI on the cytoplasmic side of the receptor. In turn, transmembrane helix VI bends away from helix III resulting in a large movement of ICL3, which opens up the site for interaction with G protein. 38 The structural changes correlate with predicted changes of chemical shifts in ICL3 (see Fig. 8 ). Mutational and structural studies show that the C-terminal domain, in particular the region near helix VIII, is involved in G protein-activation as well as interactions with other signaling proteins 62 explaining predicted changes of chemical shift in the Cterminal region. The limited number of residues undergoing notable changes of chemical shift offers themselves as suitable targets for selective amino acid labeling to study the mechanism of receptor activation by solid-state NMR.
Selection of NMR resonances according to their expected change of chemical shifts upon receptor activation must not be the sole consideration when planning selective-labeling schemes. It is also of importance to consider what kind of amino acid labeling would result in the least superposition of resonances to probe a molecular event of interest. 59,63,64 The aromatic amino acid tryptophan (Trp), for example, can be an attractive target for investigations because of its relatively low occurrence (eight) in the CB 2 receptor and its critical role in function such as toggle switch in a ligand-binding pocket. 38 Inclusion of 19 F-tryptophan by recombinant expression may also be utilized as a powerful NMR probe. 65 Figure 9 shows the predicted two-dimensional 13 C a (n)A 13 C@O(n) and 13 C@O(n)A 15 NH(n 1 1) correlation spectra for a specifically 13 C-Trp-labeled CB 2 receptor with uniform 15 N-labeling, corresponding to the inactive and active states [ Fig. 9(a,b) , respectively]. The better resolution of resonances in the 13 C@O(n)A 15 NH(n 1 1) correlation spectrum is particularly useful for signal assignment. The presence of Trpresidues around the ligand binding site is also useful for locating an isotope-labeled ligand in the protein. Fig. 9(d) ]. Considering that a method for efficient, selective Trp-labeling of CB 2 receptor has been established, 37 and that Trp is likely to be involved in ligand-binding and receptor-activation, 38 investigations on the ligand binding pocket by solid-state NMR using isotope-labeled ligands and receptor seem feasible. The NMR experiments on uniformly 13 C-, 15 Nlabeled CB 2 receptor and the spectra predicted from molecular dynamics simulations on receptor activation suggest that mechanisms of receptor activation can be studied by following a limited number of resonances from selectively labeled amino acids. 15 NH(n 1 1) dipolar interaction correlation plot for Trp(n) and the next amino acid residues (n 1 1). The spectra were predicted by SHIFTX using structures generated by MD simulations. The circles at each cross peak indicate spectral ranges corresponding to the diameters of 0.5, 1.0, and 1.5 ppm. (c) 13 C-labeled cannabinoid agonist CP-55,940 at the branched methyl groups in the nonyl tail. (d) 13 C-CP-MAS spectra of the 
